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Introduction
Functional magnetic resonance imaging (fMRI) is widely used for mapping spatial and temporal patterns of brain activity. The most common measurement is the blood oxygenation level dependent (BOLD) signal, which results from changes in local deoxyhemoglobin content (Ogawa et al., 1993) . When the brain is activated, an unexpected physiological phenomenon occurs: local cerebral blood flow (CBF) increases much more than the cerebral metabolic rate of oxygen (CMRO 2 ) (Fox and Raichle, 1986) , decreasing both local oxygen extraction fraction and local deoxyhemoglobin content. Deoxyhemoglobin is paramagnetic and creates magnetic field distortions within and around blood vessels, thereby decreasing the MR signal. Thus decreased blood deoxyhemoglobin content results in the basic BOLD effect of increased MR signal with neural activation. However, interpreting relative levels of BOLD signal change in terms of neural activity is difficult due to the BOLD signal's complex dependence on changes in cerebral blood volume (CBV) in addition to CBF and CMRO 2 . Although this sensitivity of the BOLD signal to multiple factors creates some difficulty in interpreting the signal, it also offers the possibility of estimating changes in CMRO 2 when BOLD and CBF measurements are combined.
The calibrated-BOLD approach proposed by Davis et al. (1998) does just this; it combines measurements of CBF and BOLD responses to neural activation and hypercapnia stimulation with the goal of estimating the CMRO 2 change during brain activation. Changes in O 2 metabolism are important as they are expected to reflect the underlying energy requirement of evoked neural activity (Lin et al., 2010) . This multimodal imaging approach combining BOLD and CBF measurements requires a theoretical framework that accurately describes how the BOLD signal depends on changes in CBF, CMRO 2 and CBV. The Davis model is one such framework and has been used in nearly all subsequent applications of calibrated BOLD. As originally derived, this nonlinear model essentially describes the extravascular signal change with the assumption that it depends on both the change in venous oxygenation and the change in venous CBV. These changes in turn are related to alterations in CBF and CMRO 2 in an equation involving two parameters, α and β. The parameter β was originally meant to describe a nonlinear MR signal dependence on venous oxygenation, reflecting the idea that deoxyhemoglobin has a weaker effect on the signal change in the smallest vessels compared to larger veins because of the effects of diffusion (Ogawa et al., 1993) . Similarly, the parameter α was meant to be the exponent in a power law relationship between blood flow and venous blood volume. Finally, there is an overall scaling parameter M, typically determined by a separate hypercapnia experiment, that depends on the amount of deoxyhemoglobin present in the baseline state and details of the image acquisition. The calibration step with hypercapnia uses the same model to determine M, and requires two assumptions: hypercapnia changes CBF but not CMRO 2 (Chen and Pike, 2010; Jones et al., 2005; Sicard and Duong, 2005) and CBV has the same dependence on CBF in the activation and hypercapnia experiments.
However, the Davis model is potentially oversimplified: it only considers extravascular signal changes and leaves out intravascular contributions to the BOLD signal (Boxerman et al., 1995) ; it neglects the possibility that changes in deoxyhemoglobin containing CBV (capillary and venous) may be proportionally smaller than the arterial CBV changes (Chen and Pike, 2009a; Hillman et al., 2007; Kim et al., 2007; Kim and Kim, 2006) ; and volume exchange effects were neglected, ignoring the possibility that differences in the intrinsic signal between blood and tissue may change the overall signal upon neural activation Leontiev and Buxton, 2007; Obata et al., 2004) . To clarify the assumptions involved, we retain α as a parameter in the Davis model, but define the exponent representing the relationship between CBV and CBF as φ. The original assumption setting α=φ=0.38 based on experiments in non-human primates (Grubb et al., 1974) assumes that CBV changes are proportionally equal for all blood compartments. The second parameter was assumed to be β=1.5, based on Monte Carlo simulations of only the extravascular signal dependence on deoxyhemoglobin at 1.5T (Davis et al., 1998) .
Previous models of the BOLD effect have sought to address these deficiencies. Buxton et al. (1998) , with corrections and improvements by Obata et al. (2004) , incorporated intravascular signal changes and volume exchange effects by modeling the BOLD signal change as a volume-weighted sum of signal from two compartments: intravascular (venous) and extravascular. More recent models have directly addressed the issue of relating CBV changes to CBF by incorporating direct measurements of CBV in calculating CMRO 2 (Donahue et al., 2009; Lin et al., 2008; Lu et al., 2004) . These studies used the VASO technique to measure changes in total CBV, but this approach requires two additional assumptions: (1) an absolute baseline CBV value must be assumed to derive the fractional change in CBV necessary for use in the Davis model, and (2) the venous CBV change is assumed to be proportional to the total CBV change measured with VASO. Moving beyond steady-state modeling of BOLD, other approaches have sought to incorporate transient dynamics of CBV (Kim and Kim, 2010b) , deoxyhemoglobin (Mandeville et al., 1999) , and CMRO 2 (Buxton, 2010; Hyder et al., 2010) or explain the coupling and uncoupling of CBF and CMRO 2 (Friston et al., 2000; Zheng et al., 2010 ) that underlies the BOLD signal.
The focus of this work was to model the steady-state BOLD signal and examine how it can be combined with measurements of CBF in order to calculate CMRO 2 more accurately. To do so, we followed the approach taken by Uludag et al. (2009) in which the Obata-Buxton model (Buxton et al., 1998; Obata et al., 2004 ) was expanded to not only include intravascular signal changes but also volume exchange effects. We did not linearize the model, because we were concerned that intravascular signal changes are actually quite large and would therefore violate the linearization assumption. Based on the knowledge that the BOLD signal is primarily a result of changes in the local deoxyhemoglobin content, we modeled the BOLD response as the volume-weighted sum of signals from four compartments: an extravascular tissue compartment and three blood compartments separated into arteries, capillaries and veins to allow for differences in the blood volume distribution between the three blood compartments at baseline (ω a,c,v ) and the fractional changes with activation (φ a,c,v ). This detailed analytic steady-state BOLD prediction model (the "detailed model") allows for arbitrary changes in CBF and CMRO 2 as well as arbitrary coupling of CBV and CBF. We do not explicitly examine transient aspects of the BOLD signal, and instead focus on approximate steady-state conditions, corresponding to typical calibrated BOLD applications using block design stimulus presentations. Furthermore, we make no assumptions about the relationship between CBF and CMRO 2 responses. Instead, CBF and CMRO 2 are varied independently allowing examination of the full range of BOLD effects. Finally within our model, we include the ability to alter hematocrit (Hct), baseline O 2 extraction fraction (OEF 0 ), echo time (TE), the intrinsic intravascular to extravascular signal ratio (λ), the intrinsic extravascular signal decay rate ( ), and arterial O 2 saturation (S A O 2 ) in order to more accurately model the BOLD effect and increase our understanding of the relationship between BOLD, CBF and CMRO 2 .
We addressed the following questions using the detailed model:
1. By allowing α and β to be free parameters, can the Davis model be optimized to improve its performance in calculating changes in oxygen metabolism?
2. How large are the errors in oxygen metabolism calculations associated with using the Davis model (with either the original or with optimized values for the parameters α and β), and do these errors vary for different coupling ratios of CBF and CMRO 2 changes?
3. How sensitive are CMRO 2 calculations to variations of the physiological state, particularly the blood volume distribution at baseline and the balance of arterial and venous CBV changes with activation?
4.
If the assumptions underlying the hypercapnia calibration experiment (no effect on CMRO 2 and the same relationship between CBF and CBV as during neural activation) are incorrect, how will this impact calculations using the Davis model?
Our primary finding is that despite the oversimplifications of the Davis model, the same mathematical form of the Davis model with corrections to α and β adequately captures the behavior of the much more complex physiology described by the detailed model. The classic Davis model is reasonably accurate for most activation experiments in which both CBF and CMRO 2 increase in parallel, without optimization of α and β provided that M is accurately measured. However, studies of the response to drugs such as caffeine have shown more divergent effects, lowering CBF and possibly increasing CMRO 2 , which leads to inaccuracies in calculations by the original Davis model. Parameter optimization improves the accuracy of the Davis model across the full range of potential CBF and CMRO 2 responses. By permitting α and β to be free parameters, though, their physical interpretation becomes complicated in that they no longer correspond to their original meaning. While variation of many of the physiological parameters has a strong effect on the magnitude of the BOLD response, this effect is adequately captured in the scaling parameter M, so that Davis model estimates of CMRO 2 change remain relatively accurate even with fixed α and β. The primary physiological parameters for which this is not true are related to CBV, both the baseline distribution between compartments and the balance between arterial and venous changes. Additional errors due to assumptions about the hypercapnia calibration are largest when the CBF change is much larger than the CMRO 2 change. These results emphasize the necessity of accurately determining how CBV distributes with activation and also the importance of measuring M values accurately for each subject. In this paper, our focus is on the Davis model, and its ability to calculate CMRO 2 changes from BOLD and CBF data, because the Davis model is particularly well-suited for the calibrated BOLD experiment. In future studies, we will examine the effects of hypoxia and the accuracy of other models in predicting the BOLD signal.
Theory
The Davis model for calibrated-BOLD is presented and the associated assumptions are analyzed. A detailed four-compartment model for the BOLD response is developed and implemented using Matlab. Note that upper case variables describe absolute quantities (e.g., F is CBF, the blood inflow to the arteriolar compartment in units of ml blood/ml tissue-sec, and V a is the arteriolar blood volume fraction in units of ml blood/ml tissue), while lower case variables represent the same quantity normalized to its baseline value (e.g., f and v a are dimensionless and equal to 1 at rest). Similarly, Δ denotes an absolute change while δ specifies a percent change from the baseline state.
The Davis model
With this nomenclature in mind, the Davis model relates f and normalized CMRO 2 , r, to the percent change in the BOLD signal (δS) using the following equation:
As originally derived, the mathematical form in the brackets represents the idea that the signal is modulated both by changes in the volume of blood containing deoxyhemoglobin (modeled with the first term in f relating CBV to CBF by a power law) and also by the magnetic susceptibility of the blood (modeled by the second term in r and f).
The r/f term models the susceptibility effect due to a change of deoxyhemoglobin concentration in the venous blood. The parameter β was introduced based on Monte Carlo simulations of water molecule diffusion around magnetized vessels to describe how the signal depends on the susceptibility. This dependence is expected to differ between large and small vessels because of the effects of diffusion on the extravascular signal change near the smaller vessels. The typical value used is β=1.5 (Davis et al., 1998) , although it has been argued that the value should be reduced at higher magnetic field strengths (Boxerman et al., 1995; Chiarelli et al., 2007b; Ogawa et al., 1993) .
The third parameter, M, essentially lumps together a number of effects that modulate the magnitude of the BOLD response, including aspects of local brain physiology and image acquisition parameters. In particular, M varies with the amount of deoxyhemoglobin present in the baseline state. It is typically calculated from an additional experiment using combined BOLD and CBF measurements obtained in response to hypercapnic stimulation. This assumes there is no change in CMRO 2 (r=1) and that CBV with activation (AC) and with hypercapnia (HC) changes in the same way in response to CBF changes (φ HC =φ AC ) as noted above.
Development of a Detailed Model of the BOLD Response
The calibrated BOLD methodology depends on an accurate model of how the BOLD signal is related to the mismatch between CBF and CMRO 2 , which is often expressed as the coupling parameter, n, defined as the ratio of the fractional changes (e.g., a 50% increase in CBF accompanied by a 20% increase in CMRO 2 would be n=2.5). The model presented here, following the approach by Uludag et al. (2009) , separates the signal into four compartments: one extravascular and three intravascular. Previous models have included multiple compartments to varying degrees (Blockley et al., 2009; Donahue et al., 2009; Obata et al., 2004 ). The Davis model considers only the extravascular compartment, neglects blood volume exchange effects, and assumes CBV changes are uniformly distributed across vascular compartments. The Obata model (Obata et al., 2004) explicitly includes both intravascular and extravascular components, however it only includes exchange effects with venous CBV thereby neglecting significant changes occurring in the arterial vasculature. More recent models examined effects of both arterial and venous compartments on the BOLD signal, but neglected effects of the capillary compartment (Donahue et al., 2009; Lin et al., 2008) . These models also do not account for differing dependencies of arterial and venous CBV on CBF, variable baseline distribution of CBV, differences in the intravascular to extravascular proton density, and baseline extravascular signal decay rate constant ( ). where [3] Here, V denotes the volume fractions of the individual compartments (E=extravascular, I=intravascular, A=arterial, C=capillary, and V=venous). Baseline is denoted by the subscript "0" (V 0 ). The parameter ε is the signal ratio at baseline of an intravascular volume to extravascular volume (e.g. ε v is the signal ratio in the experiment between equal volumes of venous blood and extravascular tissue). TE is the echo time of the MR measurement, and is the change in the MR signal relaxation rate with the stimulus for each of the four compartments, three intravascular and one extravascular.
Volume fractions were determined by examining a range of total baseline intravascular volume fractions (V I,0 ) and fractional distributions (ω) as shown in Table 1 . Changes in total CBV were modeled as in Grubb et al. (1974) by assuming a power law relationship to CBF with exponent φ. Distributions of ΔCBV to the compartments containing deoxyhemoglobin were calculated separately using different exponents (φ c and φ v ) for capillary and venous ΔCBV respectively. Ranges of φ and φ v were examined while φ c was assumed to be half of φ v reflecting small changes in capillary CBV (Stefanovic et al., 2008 
Simulations and Results
Following the outline presented in Figure 1 , we determined a set of typical physiological values for the detailed model inputs (Table 1) , and used this simulation to optimize the Davis model parameters α and β. Next, we used the detailed model to simulate changes to the BOLD activation and hypercapnia responses as the physiological parameters vary. The focus of the simulations was to test the accuracy of CMRO 2 estimates from the calibrated BOLD experiment using the Davis model, although the effect of different physiological parameters (e.g., hematocrit) on the BOLD response is interesting in itself. Here, we are essentially asking the question of whether the simple calibration step accurately captures the variability of the BOLD response due to variation in particular physiological parameters.
Producing Simulated BOLD Data for a Standard Subject
For imaging parameters, we assumed a 3T system with TE=32 ms. For the standard subject, the total intravascular volume fraction at rest was assumed to be V I,0 =0.05 (Roland et al., 1987) . The fractional distribution of CBV at baseline (ω) between arteries, capillaries and veins was assumed to be ω a =0.2, ω c =0.4 and ω v =0.4 consistent with intra-cortical measurements of CBV distribution (Weber et al., 2008) . The exponent relating f to total v was assumed to be φ=0.38 (f=v φ ) as in Grubb et al. (1974) . The venous CBV was assumed to change by a smaller fraction than the total CBV change, with the exponent φ v =0.2 relating normalized venous volume (v v ) to f (Chen and Pike, 2009a) . The capillary volume change exponent was assumed to be half of φ v (φ v =0.1) (Stefanovic et al., 2008) . Arterial ΔCBV was then calculated to be the remainder of total ΔCBV resulting in an effective φ a =1.1 at f=1.5.
Venous oxygenation at baseline was determined from equation A7 (Appendix) assuming S A O 2 =98% (Schutz, 2001 ) and OEF 0 =0.4 (Marchal et al., 1992) . Activation S V O 2 was determined across a range of f and r using equations A6 and A7 (Appendix). Capillary oxygen saturation was calculated from S A O 2 and S V O 2 using equation (A8) with κ=0.4 effectively giving a slightly greater weight to venous blood (Tsai et al., 2003) . Hct was set to 0.44, and the baseline tissue relaxation rate constant ( ) was assumed to be 25.1 s −1 based on previous 3T studies from our group (Perthen et al., 2008) . Changes in were calculated using equations A9 and A10. Table 1 includes the full list of standard parameter values and resulting intermediaries such as values of associated with each compartment.
The intravascular to extravascular intrinsic signal ratio was experimentally determined using a GE Signa Excite 3-T whole-body system with a body transmit coil and an 8-channel receive-only head coil. Two subjects were imaged using a high-resolution flow-compensated spoiled-GRASS protocol with TR/TE/α=4000 ms/5.4 ms/10°. Images were viewed using AFNI (Cox, 1996) . Intravascular measurements were taken from the sagittal sinus while extravascular measurements were taken from the visual cortex gray matter. The spin density ratio was then calculated from the signal ratio to be 1.15. This fraction allows calculation of the intrinsic intravascular to extravascular signal ratio using equation A2 (Appendix). For arteries, capillaries and veins, this resulted in intrinsic signal ratios of ε A =1.30, ε C =1.02, and ε V =0.50 (Table 1) . With these values, volume exchange effects will add to the BOLD response for arterial changes, subtract from the BOLD response for venous changes, and have little effect for capillary changes.
Optimization of the Davis Model
Numerical simulations-For this standard set of parameters, the detailed 4-compartment model was used to calculate the BOLD signal for arbitrary changes in CBF (f) and CMRO 2 (r) (Fig. 2a ). In the current simulations, f was varied from 0.7 to 1.8 and r was varied from 0.8 to 1.4. BOLD hypercapnic calibration was simulated for f=1.6 and r=1 (marked by 'x' on Fig. 2); this is a typical CBF change measured for 5% CO 2 inhalation (Ances et al., 2009; Perthen et al., 2008) . Optimization of α and β of the Davis model was performed by normalizing the simulated BOLD data to the simulated hypercapnic BOLD signal. The Davis model equation was similarly normalized to this hypercapnia (subscript HC) value of δS HC and f HC =1.6 thereby eliminating the scaling parameter, M (Fig. 1d) . Using the Matlab function fmincon, non-linear parameter optimization of α and β was performed using this simulated and normalized BOLD signal associated with the standard subject. Fitting was performed across the entire δCBF-δCMRO 2 plane thereby making α and β insensitive to specific values and coupling ratios of blood flow and oxygen metabolism.
Simulation results-The optimized values of α=0.14 and β=0.91 are designated the "optimized" parameters while the original values of α=0.38 and β=1.5 are designated the "classic" parameters. The Davis models associated with these parameters are similarly notated. The BOLD surfaces predicted with the Davis model using the optimized and classic parameter values are shown in Figure 2b and c. The classic Davis model predicts a modest systematic difference in the BOLD signal while the optimized Davis model produces a signal nearly identical to that of the detailed model. We also performed this optimization of α and β for large ranges of the detailed model inputs: , (Fig. 3 ). Of these physiologic variables, the best-fit value of α shows the strongest dependence on φ v (Fig. 3a) while β shows the strongest dependence on ω v (Fig. 3b) . The fitted α and β showed somewhat weaker dependence on tissue properties and baseline deoxyhemoglobin content ( Fig. 3c-f ). Optimized α is approximately linearly dependent on these parameters. Simultaneously, β shows quadratic dependence on baseline CBV distribution (ω v ) and linear dependence on φ v , the tissue parameters ( and λ), and the baseline deoxyhemoglobin content parameters (Hct and OEF 0 ). α and β are much less dependent on the other inputs to the detailed model (see supplementary data, Fig. S1 ).
Error in δCMRO 2 Calculations Associated with the Davis Model α and β
Numerical simulations-Given the classic and optimized values for α and β, we then tested the primary question related to the calibrated BOLD experiment: how large are the errors in estimation of CMRO 2 change when using the Davis model, and does this depend on the particular combination of CBF and CMRO 2 changes? For the second part of the question, we were particularly interested in three combinations of CBF/CMRO 2 coupling, which we can characterize by the coupling ratio n: δCBF/δCMRO 2 . The first is in the region n=2.5 (δCBF=50%, δCMRO 2 =20%), corresponding to activation results in a number of calibrated BOLD studies using the classic Davis model (Perthen et al., 2008; Stefanovic et al., 2004) . The second is n=5 (δCBF=50%, δCMRO 2 =10%), a higher ratio that some PET studies have found (Ito et al., 2005) . The third was motivated by studies of the effects of caffeine, which lowers CBF and raises CMRO 2 (δCBF=-25%, δCMRO 2 =30%, n=−0.8) (Griffeth et al., 2011) . In these simulations we assumed that hypercapnia changes only CBF, with no effect on CMRO 2 . To simulate the calibrated BOLD experiment, M values for both the classic and optimized Davis models were determined using eqn.
[1] and the BOLD response from the detailed model at f HC =1.6 and r HC =1.0 (marked with an 'x' in Figure 2a ). This results in values of M=11.1 and M=14.9 for the classic and optimized Davis models respectfully. Using these values for M, The two Davis models were then compared in their ability to accurately predict δCMRO 2 from the simulated BOLD and CBF data by comparing the percent error from actual δCMRO 2 . Errors in δCMRO 2 estimates by both models were determined using eqn.
[5]: [5] Simulation results-Errors in estimated δCMRO 2 are displayed across the δCBF-δCMRO 2 plane in Figure 4 . Note that both δCMRO 2 and ζ are percentages, although δCMRO 2 is the percent change in absolute CMRO 2 while ζ is the percent error relative to the actual percent change (e.g., if true δCMRO 2 is 10% and the estimated δCMRO 2 is 15%, the percent error is ζ=50%). Errors for specific combinations of δCBF and δCMRO 2 are listed in Table 2 . It is clear that the classic Davis model using α=0.38 and β=1.5 systematically underestimates δCMRO 2 ( Figure 4a and Table 2 , column 1). Along the coupling parameter contours of n=2.5 and n=5, this underestimation is close to −10%. Specifically for n=2.5 (δCBF=50% and δCMRO 2 =20%), the classic Davis model underestimates δCMRO 2 by −9.8% such that it reports a change of 18.0% when it is actually 20%. Even for a much larger value of the coupling parameter such as n=5.0 (δCBF=50% and δCMRO 2 =10%), the Davis model is only −6.9% in error. Yet, the optimized model improves the accuracy of CMRO 2 calculations. For δCBF=50% and δCMRO 2 =20%, the Davis model with optimized parameters predicts δCMRO 2 =19.7% (ζ=−1.3%) while for a higher coupling of δCBF=50% and δCMRO 2 =10%, the optimized model returns δCMRO 2 =9.8% (ζ=−2.5%). For the region with decreased CBF (−25%) but increased CMRO 2 (30%) the error using the classic model was ζ=−38.0% while with the optimized model it was reduced to −1.2%.
Error in δCMRO 2 Calculations Due to Physiological Variation
Numerical simulations-The previous simulations showed that the Davis model with optimized α and β works well for estimating δCMRO 2 for the physiological parameter set defined in Table 1 . In practice there is likely to be substantial variation of these parameters across subjects even for a healthy population. As described in section 3.2, we found that the optimal values of α and β do depend on these physiological parameters, and in a typical experiment there will not be sufficient information available to adjust the values of α and β. The important question for the calibrated BOLD method is then: if we adopt the values of α and β optimized for our "best guess" at the underlying physiology (Table 1) , how large are the errors in the estimate of δCMRO 2 if these physiological parameters vary? To assess the errors in the estimation of δCMRO 2 we varied the value of each physiological parameter in the detailed model and then simulated the calibrated BOLD experiment to measure δCMRO 2 with either the classic or optimized Davis models. The physiological parameters were varied over the following ranges: φ v =0-0.65, ω v =0.2-0.6, , λ=0.9-1.3, Hct=0.25-0.65, OEF 0 =0.25-0.65, V I,0 (0.01-0.1), φ (0.3-0.65), TE (20-40 ms), and λ (0.9-1.3). A range for φ c (0-0.3) was also examined but found to have little effect on calculations of δCMRO 2 . Therefore, φ c was assumed to be equal to half of φ v consistent with small changes to capillary volume during activation. Simulated hypercapnia calibration was repeated for each variation in order to calculate M; note the classic value of M is similar to what is typically calculated for experimental data using the Davis model (Fig. 5) . The impact of the physiological variations was assessed for two scenarios of combined CBF and CMRO 2 change: n=2.5 and n=−0.8 simulating the effects of caffeine. Both of these combinations were analyzed with the two Davis models to determine how accurate the models' estimates of δCMRO 2 would be, i.e. how close to δCMRO 2 =20% or 30% (Table 2) .
Simulation results-For n=2.5, varying φ v in the range of 0-0.65 has the largest impact on δCMRO 2 estimates with the classic model estimating δCMRO 2 =15.0-30.0% and the optimized model estimating δCMRO 2 =16.2-34.2% (Fig. 6a) . Variations in δCMRO 2 calculations produced by Hct, ω v , and were secondary, while the smallest impacts on δCMRO 2 calculations were produced by altering V I,0 and φ (see supplementary data, Table  S1 for exact ranges). This was despite very large ranges of V I,0 (0.01 to 0.1 while literature values are typically about 0.05) and φ (0-0.65). At n=−0.8, φ v again had a significant influence. However at this combination of δCBF and δCMRO 2 , ω v in the range of 0.2-0.6 produced the largest variance while (15-45 s −1 ) also had a sizeable effect (Fig. 6b) . Meanwhile, the impact of λ, OEF 0 and to a lesser extent V I,0 also increased above that of Hct and TE. φ still had very little impact.
As it was determined that the venous CBV change (φ v ) had the biggest impact on the accuracy of the Davis model, we more closely examined how variations in φ v affected the Davis model for the cases of φ v =0, 0.2, 0.38, and 0.65. Again, the hypercapnia experiment was simulated using BOLD data from the detailed model to calculate M for each case. We then analyzed the simulated BOLD data associated with the standard subject across the δCBF-δCMRO 2 plane for each value of φ v using the two Davis models. Using eqn. 5, we calculated the percent error associated with each point in the f-r plane (Fig. 7) . As expected, the optimized Davis model fits best at φ v =0.2, but overestimates changes in CMRO 2 if φ v =0.38 or 0.65, and underestimates changes in CMRO 2 when φ v =0. Although not shown, the classic Davis model fits the simulated data for φ v =0.38 somewhat better but is still not as accurate as the optimized model at φ v =0.2.
To address the finding by Lin et al. (2008) that φ=0.65 with activation, we examined in more detail how this would affect δCMRO 2 calculations. We repeated the process used to produce Figure 7 for both the classic and optimized Davis models but set φ=0.65 rather than φ=0.38 and combined this with the same four values of φ v . The images for φ=0.65 are not shown, since they are practically identical to those in Figure 7 (φ=0.38) . This was expected due to the minimal impact φ had on δCMRO 2 calculations as shown in Figure 6 . This suggests that the venous volume change, rather than the overall volume change, is the key physiological parameter that determines the accuracy of the Davis model estimates of δCMRO 2 .
Potential Error in δCMRO 2 Calculations Associated with Hypercapnia Calibration
Numerical simulations-The hypercapnia calibration process assumes that inhalation of low levels of CO 2 (typically ~5%) does not affect CMRO 2 in the brain. In calculations up to this point, we assumed our method of calibration was accurate, but more recent experiments on hypercapnia calibration suggest that inhalation of 5% CO 2 decreases CMRO 2 , with recent estimates giving this decrease between −13% and −26% (Bolar et al., 2010; Xu et al., 2011) for CBF changes of 55% and 32% respectively. To simulate this, we calculated the hypercapnic BOLD signal from the detailed model simulation for f HC =1.6 and r HC varied from 0.8 to 1.1, but we calculated M from equation [1] assuming r HC =1. Additionally, the dependence of CBV on CBF may differ between neural activation and hypercapnia (Chen and Pike, 2010) . To simulate this error, we took the hypercapnic BOLD signal from the detailed model simulation for f HC =1.6 and r HC =1.0 but varied φ vHC from 0 to 0.4. Again, we analyzed this signal using equation [1] to calculate M but still using α=0.14 and β=0.91, which were optimized for φ vHC =0.2.
Simulation results-For the standard subject, the true M for the classic Davis model was determined to be 11.1%, but if hypercapnia calibration decreases CMRO 2 by −10% (r HC =0.9) the scaling parameter would be overestimated (M=13.3%). We repeated the calculation of δCMRO 2 for this biased M using the classic Davis model at the three values of n (2.5, 5.0 and −0.8). We found the error in δCMRO 2 to be remarkably small at n=2.5 and δCMRO 2 =20% (21.0%, ζ=5.1%) such that the systematic error in M tends to correct systematic error in the classic α and β. At n=5.0 and δCMRO 2 =10%, this is not the case. This value of M leads to large error in δCMRO 2 (13.9%, ζ=38.9%) and underestimate of n=3.6 (Table 3) . At n=−0.8 and δCMRO 2 =30% instead of correcting the error associated with the classic α and β, the hypercapnia M magnified the error and grossly underestimated δCMRO 2 (12.7%, ζ=−57.7%) (Table 2, column 3). Errors associated with biases due to both non-iso-metabolic hypercapnia calibration and concurrent variation of all other input parameters as in section 3.4 followed a similar systematic pattern of error (supplementary data, Table S1 ). The errors in δCMRO 2 for different degrees of CMRO 2 change with hypercapnia are shown in Figure 8a .
If the relationship between CBV and CBF between activation and hypercapnia experiments changes, this also leads to bias in M. One study suggested that φ vHC is less than φ v due to activation (0.15 versus 0.23 respectively) (Chen and Pike, 2010) . If this is the case, then this would again lead to M being overestimated (M=11.4%). This error is much lower than the error associated with r HC =0.9, although it would result in δCMRO 2 calculations associated with n=2.5 and n=5.0 also being overestimated while for n=−0.8 δCMRO 2 will be underestimated (Fig. 8b) .
Discussion
The calibrated BOLD method introduced by Davis and colleagues (Davis et al., 1998) offers one of the best noninvasive tools currently available for measuring changes in oxygen metabolism in the human brain with good spatial and temporal resolution. Estimating the fractional CMRO 2 change between two states (e.g., baseline/activation or pre/post drug administration) requires three things: measurement of both the CBF and BOLD signal differences; a mathematical model of how the BOLD response depends on δCBF and δCMRO 2 ; and a calibration experiment to determine an overall scaling factor for the BOLD response (M). Here, we examined the accuracy of these latter two requirements as they relate to the Davis model. This simple model describes the BOLD response as a function of δCBF and δCMRO 2 with three parameters: M, α and β. It has become the standard model for the calibrated BOLD experiment, with α and β assumed to have fixed values of α=0.38 and β=1.5. M is determined from a hypercapnia experiment, with the assumption that mild hypercapnia alters CBF but not CMRO 2 . In this paper we have analyzed the accuracy of the Davis model with a specific focus on the expected errors in the estimate of δCMRO 2 in the calibrated BOLD experiment. We developed a detailed analytical four-compartment model of the BOLD signal for a magnetic field strength of 3T that includes a number of physiological parameters that could potentially affect the BOLD response, including hematocrit, oxygen extraction fraction, cerebral blood volume, and the distribution of blood volume changes between arterial and venous vessels as CBF changes.
Our detailed model of the BOLD response is an expanded version of other modeling approaches, which have sought to improve upon our physiologic understanding of the dependence on changes in blood volume and deoxyhemoglobin (Blockley et al., 2009; Buxton, 2009; Lin et al., 2008; Obata et al., 2004; Stephan et al., 2007; Uludag et al., 2009 ). However, the way we have used the model in the current study is somewhat different. Although the detailed model is much more complete than the simple Davis model, models such as this are difficult to adapt directly to the calibrated BOLD experiment because there are too many unknown variables. The power of the Davis model is its simplicity, with many potential physiologic sources of variability lumped into a single scaling parameter M that is measured individually. Despite the number of physiological variables that affect the BOLD signal, the surface of BOLD signal as a function of δCBF and δCMRO 2 is relatively smooth, so it is plausible that a simpler mathematical form such as the Davis model can provide a reasonably accurate approximation. To that end, we improved the Davis model by allowing α and β to be free parameters and performing non-linear parameter optimization to find the values that best fit the BOLD signal generated by the detailed model. By generating simulated data for a wide range of physiological conditions, we were able to test the ability of the Davis model, with either the classic or optimized values of α and β, to accurately calculate changes in δCMRO 2 . We examined the impact of both variations in the underlying physiology and systematic errors related to the assumptions about the effects of hypercapnia in the calibration experiment. In analyzing such errors it is important to note that they are not uniform for all combinations of δCBF and δCMRO 2 , and here we looked in detail at three values of the coupling ratio n (δCBF/δCMRO 2 ): n=2.5 and n=5, corresponding to a range of values reported for stimulus responses, and n~−0.8, a value we recently found for the effects of caffeine (lowered CBF but raised CMRO 2 ).
The key results are as follows:
1. The simulated data from the detailed model predict an M value close to what is typically observed, supporting the assumptions and parameter values underlying the model.
2.
The Davis model fits this simulated data very well if α and β are allowed to be free parameters, although this requires that one abandon the physical meaning of these parameters as they were originally derived.
3.
If there is physiological variation from the standard physiology used to optimize α and β, then the error expected in δCMRO 2 calculations is largest for variation in the venous CBV at baseline and the venous CBV change with activation.
4.
If hypercapnia reduces CMRO 2 , or produces smaller the venous volume changes for the same CBF relative to activation, then δCMRO 2 will be overestimated for the activation response but underestimated for the caffeine response.
These results are discussed in detail below.
The Davis model scaling parameter is simulated well by the detailed model
For the values of α and β optimized to the standard physiology defined in Table 1 , the classic Davis model analysis of the simulated data results in M=11.1%. In comparison, using the classic parameters and correcting for TE, a sampling of published hypercapnia M values range from 7.0 to 14.1 (Chiarelli et al., 2007b; Hoge et al., 1999; Mark et al., 2011; Perthen et al., 2008; Stefanovic et al., 2006) . This demonstrates that the detailed model reasonably simulates the BOLD signal. The simulations also show that the exact value of M varies significantly with variation of the baseline physiological parameters, particularly those parameters affecting total baseline deoxyhemoglobin including Hct, OEF 0 , V I,0 and ω v . (see Figure 5 ), emphasizing the importance of experimentally measuring M in the calibrated-BOLD experiment. In fact, variation in published M values may be due to physiological variation between subjects and regions of interest. Particularly, regional variation in baseline CBV fraction (V I,0 ) (Chugh et al., 2009 ) may account for differences in M between the motor cortex and visual cortex in the above referenced papers. For this reason, using a theoretical estimate of M for a standard set of physiological conditions is likely to introduce significant error in the estimation of CMRO 2 (Lin et al., 2008) .
Optimization of Davis Model Parameters, α and β, Improves Fit to Simulated Data
Despite the restrictive assumptions that went into its derivation, the errors in the estimate of δCMRO 2 using the classic Davis model are modest for most activation experiments. The classic Davis model with an accurately determined M systematically underestimates δCMRO 2 by about −10% (see Fig. 4 ). Even for a much higher value n=5.0, the Davis model with the true M value underestimates δCMRO 2 by only −6.9%. However, for more unusual combinations of CBF and CMRO 2 change the errors can be quite a bit larger. For example, for n=−0.8 (increased CMRO 2 but decreased CBF) the error balloons to −38.0%. Using the parameter values α=0.14 and β=0.91, optimized for the standard set of physiological parameters defined in Table 1 , these errors are reduced, particularly for n=−0.8 where the optimized Davis model returns an error of only −1.2%.
A CBF/CMRO 2 coupling ratio described by n=−0.8 may at first glance seem physiologically unreasonable, but in fact such changes may occur in response to a drug, as we recently found for caffeine. In that study, δCBF was found to decrease by −27% (Perthen et al., 2008) . Combined with analysis of the BOLD signal using the classic parameters and a hypercapnia calibrated M, a trend toward increased CMRO 2 was found (δCMRO 2 =13.3%, p=0.067). Yet further analysis of this data using the optimized model parameters and hypercapnia calibrated M revealed a significant metabolism increase due to caffeine (δCMRO 2 =21.8%, p=0.030) (Griffeth et al., 2011) . If the hypercapnia calibration is in error (see discussion below), with hypercapnia actually lowering CMRO 2 , the true CMRO 2 change with caffeine may be as high as 30%.
As a consequence of this approach of optimizing α and β, we can neither identify α as simply the exponent relating CBV to CBF, nor can we strictly relate to deoxyhemoglobin concentration using β as in the original derivation of the Davis model. Instead, α and β are effectively capturing several sources of variation arising in the detailed model, and they should just be regarded as fitting parameters. Keeping this in mind, optimal values of α and β depend on the physiologic parameters chosen for the standard state. For example, we included in our standard state the finding that relative CBV changes are larger for arteries than for capillaries and veins (Hillman et al., 2007 , Kim et al., 2007 , Chen and Pike, 2009 ). Our finding of α=0.14 after parameter optimization is consistent with this smaller venous CBV change (smaller φ v ), but α is still not equal to φ v implying that it is dependent on other parameters as well. Indeed, baseline CBV distribution and tissue properties also have large impacts on α and β (Fig. 3) . As more data becomes available on the true nature of the physiology, this figure will allow for α and β to be appropriately adjusted. For example, this figure shows that α is most affected by and tracks linearly with φ v such that when the assumed value of this parameter is increased, the optimized α determined by this process of non-linear parameter optimization also increases (e.g. φ v =0.38 produces an optimized α=0.24 and β=0.84).
Similarly, in the original Davis model derivation, β was used to relate extravascular to the concentration of deoxyhemoglobin, which is proportional to the ratio of O 2 fractions in activation and baseline. This ratio in turn is equal to the ratio r/f. Classically, the exponent β depended on the diameter of the vessels involved in signal creation, with β=1 for large vessels and β=2 for small vessels (Ogawa et al., 1993) . In the Monte Carlo simulations performed by Davis et al. (1998) , β was determined to be 1.5 for B 0 =1.5T. At 3T, the large vessel component of the susceptibility difference will dominate such that β at 3T should be smaller (Boxerman et al., 1995; Chiarelli et al., 2007b) . Figure 3 shows that the optimized value of β is affected by a variety of CBV and tissue parameters. Combined with the finding that α tracks with but is not equal to φ v , this confirms that the Davis model is an oversimplification that does not model influences of the BOLD signal in a straightforward manner. Instead, the two parameters of the Davis model effectively capture multiple factors affecting the BOLD signal beyond what they were originally intended to model. Therefore, one should avoid using experimentally determined values of φ v and β within the Davis model and instead perform more detailed parameter optimizations that capture the full range of physical and physiological factors that affect the BOLD signal.
Variation in CBV Distribution Has Largest Effect on the Accuracy of the Davis Model
Given the optimized values of α and β for the state defined in Table 1 , it is important to determine the errors in δCMRO 2 that will result when this model is applied but the underlying physiology differs from this standard state. Despite the limitations of the Davis model, the fact that it relies on a calibration step to measure the variable scaling parameter, M, gives it a distinct advantage as this potentially allows for the absorption of many variable baseline factors, such as V I,0 , TE, Hct and OEF 0 . That is, variation of a physiological variable that only scales the magnitude of the BOLD response, regardless of the exact values of δCBF and δCMRO 2 , will not affect the estimate of δCMRO 2 provided M is accurately measured. For example, Figure 6 shows that V I,0 , Hct, TE and φ do not have a large impact on δCMRO 2 calculations. Even large variations in V I,0 cause only small deviations in the range of calculated δCMRO 2 (Supplementary data, Table S1 ).
The physiological parameters that are not captured well by M, and so are likely to produce the largest errors in the estimation of CMRO 2 changes, are the venous CBV at baseline, the venous CBV change, , and to a lesser extent OEF 0 . These parameters may vary with brain region, stimulus type or duration, between subjects, and in health and disease. For example although Rostrup et al. (2005) found the relationship between changes in CBF and CBV to be constant across the brain, other groups have found variation in regional baseline CBV (Chugh et al., 2009) and in the temporal dynamics of CBV distribution in vessels as they dilate in response to a stimulus (Kim and Kim, 2010b) . There is also evidence of CBV changing with disease (Guckel et al., 2007) . In addition to differences in CBV, regional differences have been found in OEF 0 and (He and Yablonskiy, 2007) , and inter-subject differences have been found in baseline CBF (Ances et al., 2009 ).
To address this physiologic variation, we varied the basic parameter values over wide ranges and calculated the error in estimated δCMRO 2 . The change in venous CBV with activation (φ v ) is the most important factor in reliably estimating δCMRO 2 around n=2.5. Recent research has suggested that arterial changes dominate venous change (Chen and Pike, 2009a; Hillman et al., 2007; Kim et al., 2007; Kim and Kim, 2006) , but additional studies are needed to precisely quantify the relationship between venous CBV and CBF. Particularly, it is important to define how CBV changes are distributed dynamically, whether this changes with stimulus duration and type, and whether the relationship between CBV and CBF depends on brain region (Kim and Kim, 2010a, b) . Any of these considerations could alter φ and/or φ v thereby affecting optimization of the Davis model parameters and CMRO 2 calculations.
For n=2.5, baseline venous volume fraction (ω v ) is secondarily important while for n=−0.8 accurate knowledge of ω v and becomes much more significant, even more so than φ v . In this regime of strong uncoupling (decreased CBF with increased CMRO 2 ), baseline CBV, intravascular to extravascular spin density ratio, and baseline oxygen extraction also have sizeable although smaller effects on δCMRO 2 calculations (Fig. 6b) . As with φ v , additional research is needed to confirm the normal range of OEF 0 , V I,0 , and λ. However, it is possible to measure and λ in individual subjects and may soon be possible to reliably measure OEF 0 using MR techniques (Chen and Pike, 2009b; Lu and Ge, 2008; Qin et al., 2011) . As our knowledge of these values increases, we will be able to increase the accuracy of our model.
The importance of an accurate knowledge of φ v is emphasized in Figure 7 , which shows how accurate the optimized model is as φ v increases from 0 to 0.2, 0.38 and 0.65. The Davis model optimized for φ v =0.2 estimates δCMRO 2 very well at this value but overestimates δCMRO 2 if φ v =0.38 or 0.65, and underestimates δCMRO 2 for φ v =0. We also examined the effect of setting total φ=0.65 as found by Lin et al. using VASO (2008) and found it has little effect compared to φ=0.38 if φ v =0.2 remains unchanged. However if this volume change is distributed equally to the compartments such that φ v =0.65, then the optimized Davis model will overestimate δCMRO 2 in agreement with the results of Lin et al. (2008) and mirroring Figure 7d . Yet, the VASO technique used in the study of Lin et al. specifically measures changes in total CBV rather than venous CBV. Therefore to apply VASO data to the Davis model, it must be assumed that venous CBV changes in the same way as total CBV. Furthermore, a value for baseline CBV must be assumed in order to translate absolute volume changes into fractional changes, which are necessary for calculating the power-law relationship between CBF and CBV. Both assumptions may lead to φ v being overestimated. Specifically, experimental findings of larger changes on the arterial side do not support the large venous CBV changes associated with φ v =0.65, although more experiments are needed to confirm this. A previous study also examined whether the assumption that venous CBV changes are similar to total CBV changes would affect CMRO 2 calculations (Kim et al., 1999) . This study reported that the effects are minimal as long as a multiplicative term involving deoxyhemoglobin and volume changes is small. However, this may not be the case in all activation experiments, and furthermore this model assumes that changes in are small and only includes venous blood volume, neglecting the effects of arterial and capillary blood volume.
Violations of Hypercapnia Calibration Assumptions Lead to Errors in M and δCMRO 2
In our initial calculations, we assumed that we could accurately measure M in order to explore the effects of physiologic variation. Recent research has suggested methods other than hypercapnia for more reliably measuring M. This is an active area of research, although one method gaining popularity is hyperoxia (Chiarelli et al., 2007b; Mark et al., 2011) . To this point, though, most calibrated BOLD experiments have used hypercapnia to measure the scaling parameter M by assuming CMRO 2 is not changed by CO 2 inhalation (Chen and Pike, 2010; Jones et al., 2005; Sicard and Duong, 2005) , but there is some controversy about this assumption (Kliefoth et al., 1979; Xu et al., 2011; Zappe et al., 2008) . If hypercapnia in fact decreases CMRO 2 then this process would tend to overestimate M. At larger values of CBF-CMRO 2 coupling, this produces large errors in δCMRO 2 calculations and underestimates n. Interestingly, this underestimation of n is larger for bigger values of n. This may account for some of the discrepancies between fMRI and PET data in studies reporting larger values of n. For example, one PET study found values of n between 5 and 6 in the somatosensory cortex (Fox and Raichle, 1986) while an fMRI experiment found values closer to n=3-4 (Chiarelli et al., 2007a) . One area of CBF-CMRO 2 coupling particularly sensitive to M is decreased CBF and increased CMRO 2 as produced by caffeine. Here, overestimates of M will tend to underestimate δCMRO 2 , and it is in this area that error in both M and the parameters α and β have the largest impact on δCMRO 2 calculations (Figure 4 ).
Another assumption of hypercapnia calibration is that CBV changes in different compartments are the same for activation and hypercapnia. As Figure 8 shows, error due to differences in relative CBV changes between activation and hypercapnia followed a pattern similar to violations of the iso-metabolic assumption. If φ vHC is less than φ v (Chen and Pike, 2010) , then M and δCMRO 2 will be overestimated. If φ vHC is more than φ v , then the opposite pattern of errors is apparent. Even with the systematic error in M due to changes in CBV distribution and δCMRO 2 with hypercapnia, the Davis model is surprisingly accurate, especially close to n=2.5. This is likely due to the calibration process. Even with the inaccuracies of calibration, some self-correction of errors occurs when the same, albeit incomplete, model is used to analyze both the hypercapnia and activation data.
Future work
In this paper we have used the detailed model of the BOLD effect to assess and improve the accuracy of the calibrated BOLD method. The detailed model can also be used to address more basic questions of which physiological changes dominate the BOLD effect. Total deoxyhemoglobin, influenced by blood volume and concentration, is the most important factor. Previous models have included to different degrees separate terms for CBV (to model exchange effects) and deoxyhemoglobin concentration in blood (to model the intrinsic signal change of blood). The detailed model includes these effects and others as above, and it can be used to evaluate additional models (Buxton, 2009; Obata et al., 2004; Stephan et al., 2007) .
Finally, an area of future application of the detailed model is to analyze potential errors in CMRO 2 determination when hyperoxia is used for calibration. Hyperoxia was introduced as an alternative to hypercapnia as a way to avoid uncertainties due to the iso-metabolic assumption of the hypercapnia calibration, and because hyperoxia is more tolerable than hypercapnia (Chiarelli et al., 2007b) . However, the hyperoxia calibration makes some additional assumptions such as baseline OEF, and the impact of these assumptions can be tested with the current model. The hyperoxia approach also does not have the same selfcorrecting behavior as hypercapnia. The difference is that hypercapnia and activation both involve CBF changes and associated assumptions about how CBV is altered. In contrast when using hyperoxia calibration, only the activation part of the experiment depends on the CBF change, and hyperoxia just manipulates deoxyhemoglobin content. For this reason, calibrated BOLD using hyperoxia is likely to be more sensitive to inaccuracies in the modeling of how CBV depends on CBF. All of these effects will be evaluated with the detailed model in future work.
Conclusions
The detailed model of the BOLD response developed here provides a theoretical framework for analyzing a number of questions related to the interpretation of the BOLD response. Here, we focused on improving the accuracy of the calibrated BOLD method to estimate changes in CMRO 2 . Despite the simplicity of the Davis model, and the restrictive assumptions of the original derivation, the mathematical form of the model nevertheless provides a reasonably accurate approximation for this complex phenomenon. The accuracy of the model is improved by using optimized values of the parameters α and β calculated from the detailed model. It is important to recognize, though, that the optimized parameter values no longer correspond to the physiological effects they were originally introduced to model and should be treated simply as fitting parameters. As new experimental data becomes available, particularly an accurate understanding of the venous CBV change with activation, these optimized values can be revised based on the calculations presented here for the detailed model.
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Refer to Web version on PubMed Central for supplementary material. in general will depend on the spin density and the longitudinal relaxation time constant T 1 . Assuming T 1 does not change with activation, such that the signal at TE=0 does not change, then the following equality is formed describing the intrinsic signal ratio of blood: (A2) λ is the effective intravascular to extravascular spin density ratio, or the signal ratio when TE=0, and this was assumed to have the same value for each of the intravascular compartments. The value of λ was determined experimentally to be 1.15 (Section 3.1). Since BOLD is a fractional signal change, it can be expressed as . Noting
The intravascular transverse relaxation rate constants were approximated for each compartment using a quadratic model dependent on Hct and SO 2 (Silvennoinen et al., 2003; Zhao et al., 2007) :
The dependence of A* and C* on Hct was approximated using a linear fit of the experimental data for 3T reported in Zhao et al. (2007) .
The oxygen extraction fraction with activation was calculated from the normalized CBF and CMRO 2 , which are variable inputs to the detailed model:
Oxygen saturation for the venous compartment was determined from the arterial saturation and the oxygen extraction fraction:
Capillary oxygen saturation (S C O 2 ) was calculated as an average of arterial and venous values with weighting κ:
In calculating values, the A* terms cancel leaving dependence on Hct through C* as well as SO 2 from both the baseline and activation states. The second term denoted by the subscript 0 is associated with the baseline state.
(A9)
Note that SO 2 decreases from arteries to capillaries to veins, while capillary Hct is also 76% of the arterial value (Sakai et al., 1989) .
Extravascular change was treated as a linear combination of the contributions from each of the vascular compartments calculated separately as determined by Ogawa et al. (1993) . In general, is the sum of two components: the transverse relaxation rate in the presence of fully oxygenated blood ( R 2 ) and the signal relaxation rate due to local field inhomogeneities including the effects of deoxygenated blood (R 2 ′). When calculating , R 2 remains constant and therefore cancels leaving only the difference in which was previously estimated using Monte Carlo simulations of water proton intravoxel phase dispersion. These experiments demonstrated that depending on vessel size, has either a linear or quadratic dependence on main magnetic field strength B 0 , Hct, and SO 2 as well as purely linear dependence on blood volume fraction (V) (Ogawa et al., 1993) :
Note that Δχis the gyromagnetic ratio of protons, and SO 2,off is the O 2 saturation that produces no magnetic susceptibility difference between blood and tissue. Total extravascular is then the sum of these three blood compartment contributions. • In particular, the model incorporates volume changes of three vascular compartments.
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• New parameters for the Davis model improve estimates of oxygen metabolism
• Knowledge of blood volume will have the biggest impact on future improvements.
• Accurate measurement of the scaling parameter is a confounding factor. The optimized parameters of α=0.14 and β=0.91 produce much more accurate estimates of δCMRO 2 across the entire expanse examined. This is apparent from the green coloring across the majority of the δCBF-δCMRO 2 plane corresponding to zero error. Errors around δCMRO 2 =0 are artifacts of division by a small number. The nine input parameters to the detailed model again were altered around the standard values in Variations in Hct, ω v , and also have sizeable although much smaller effects on both models (see Table S1 for exact ranges). Variations due to V I,0 , TE, and φ are exceptionally small and are accounted for by the scaling parameter. The pattern of error at n=5.0 is similar to the pattern of error for n=2.5. (b) In the case of n=−0.8, ω v and baseline have the largest effect on δCMRO 2 calculations followed by OEFM 0 , λ, and φ v . The other parameters all also have a larger impact on δCMRO 2 calculations around this coupling of CBF and CMRO 2 suggesting that the mathematical form of the Davis model is not as reliable in this area of CBF-CMRO 2 coupling. Dashed lines represent true δCMRO 2 . r HC is the normalized change in δCMRO 2 due to hypercapnia (HC), normally assumed to be zero. φ vHC is the exponent relating venous CBV to CBF for HC, normally assumed to be equal to the corresponding value for activation (0.2 in these calculations). (a) Deviation from the assumption that hypercapnia is iso-metabolic produces large errors in δCMRO 2 calculations. A decrease in cerebral O 2 metabolism with hypercapnia as some studies suggest will result in M being overestimated. This results in CMRO 2 being overestimated for n=2.5 (green) and n=5.0 (blue) and underestimated for n= −0.8 (red). Interestingly when using the classic Davis model, Table 2 (column 3) shows that this bias in M allows for some correction due to the bias introduced by the classic parameters. (b) If the relationship between CBV and CBF between activation and hypercapnia experiments changes, this also leads to bias in the estimation of CMRO 2 . One study suggested that φ vHC is less than φ v due to activation (0.15 versus 0.23 respectively) (Chen and Pike, 2010) . Again, this would overestimate δCMRO 2 calculations associated with n=2.5 and n=5.0 and underestimate δCMRO 2 for n=−0.8. Table 2 Error in δCMRO 2 and n as calculated by the classic and optimized Davis models for the standard subject as defined in Table 1 While the optimized Davis model is best for all couplings of δCBF and δCMRO 2 , the classic Davis model with the true value of M also produces reasonable estimates of δCMRO 2 around n=2.5 and n=5.0. Calculations using the classic Davis model parameters with a biased M (as might be determined from a hypercapnia calibration) are also given, and at n=2.5 this model is also quite accurate. However, the classic Davis model with the biased M is not accurate for n=5.0 or n=−0.8. Even the classic model with the true M is not accurate for n=−0.8.
Classic α and β
Optimized α and β Classic α and β Biased M (r HC =0.9) Typical functional activation (MRI): (n=2.5) δCBF = +50% δCMRO 2 = +20% δCMRO 2 = 18.0% ξ = −9.8% n = 2.8 δCMRO 2 = 19.7% ξ = −1.3% n = 2.5 δCMRO 2 = 21.0% ξ = 5.1% n = 2.4
Typical functional activation (PET): (n=5.0) δCBF = +50% δCMRO 2 = +10% δCMRO 2 = 9.3% ξ = −6.9% n = 5.4
δCMRO 2 = 9.8% ξ = −2.5% n = 5.1 δCMRO 2 = 13.9% ξ = 38.9% n = 3.6
Typical response to caffeine: (n=−0.8) δCBF = −25% δCMRO 2 = +30% δCMRO 2 = 18.6% ξ = −38.0% n = −1.3 δCMRO 2 = 29.6% ξ = −1.2% n = −0.8 δCMRO 2 = 12.7% ξ = −57.7% n = −2.0
